Questions and Answers from the F.I.X./• Phenylpropanolamine (PPA) Withdrawal/• Intralipids and Tubing Changes/• Zyprexa Zydis/• H. Pylori Regimens in Pediatrics/• Vasopressin in ACLS/• MD Handwriting Courses
Restricted accessResearch articleFirst published online March, 2001
Questions and Answers from the F.I.X./• Phenylpropanolamine (PPA) Withdrawal/• Intralipids and Tubing Changes/• Zyprexa Zydis/• H. Pylori Regimens in Pediatrics/• Vasopressin in ACLS/• MD Handwriting Courses
The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers of The Formulary Monograph Service or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X.
Get full access to this article
View all access options for this article.
References
1.
PearsonM.L.Guideline for prevention of intravascular-device-related infections. Infect Control Hosp Epidemiol.1996; 17(7): 438–73.
2.
National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition. Safe practices for parenteral nutrition formulations. JPEN J Prenter Enteral Nutr.1998; 22(2): 49–66.
3.
Sitges-SerraA., LinaresJ., PerezJ.L.A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Prenter Enteral Nutr.1985; 9(3): 322–5.
4.
Vasopressin package insert.Shirley, NY: American Regent Laboratories, Inc.; 1996 Aug.
